Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 11.29 is 14% below its 5-year average of 13.14, around the middle of its 5-year range (4.80–24.58).
As of the fiscal period ended Wednesday, December 31, 2025. 16.21% above its 12-month average of 9.71.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
11.29
EARNINGS PER SHARE (EPS) AVG TTM
9.71
EARNINGS PER SHARE (EPS) AVG 3Y
9.57
EARNINGS PER SHARE (EPS) AVG 5Y
13.14
EARNINGS PER SHARE (EPS) AVG 10Y
10.90
EARNINGS PER SHARE (EPS) AVG 15Y
8.34
EARNINGS PER SHARE (EPS) AVG 20Y
6.79
CURRENT VS TTM AVG
+16.21%
CURRENT VS 3Y AVG
+18.00%
CURRENT VS 5Y AVG
-14.08%
CURRENT VS 10Y AVG
+3.57%
CURRENT VS 15Y AVG
+35.42%
CURRENT VS 20Y AVG
+66.16%
Labcorp Holdings Inc.
Market Cap
$25.77B
Earnings Per Share (EPS)
11.29
TTM Avg
9.71
3Y Avg
9.57
5Y Avg
13.14
Market Cap
$25.96B
Earnings Per Share (EPS)
7.85
TTM Avg
3.38
3Y Avg
2.74
5Y Avg
2.31
Market Cap
$26.04B
Earnings Per Share (EPS)
9.42
TTM Avg
8.33
3Y Avg
8.09
5Y Avg
9.83
Market Cap
$25.02B
Earnings Per Share (EPS)
7.87
TTM Avg
10.78
3Y Avg
11.05
5Y Avg
10.65
Market Cap
$23.72B
Earnings Per Share (EPS)
7.82
TTM Avg
6.79
3Y Avg
7.36
5Y Avg
7.17
Market Cap
$28.06B
Earnings Per Share (EPS)
42.71
TTM Avg
41.42
3Y Avg
39.43
5Y Avg
36.04
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $25.77B | 11.29 | 9.71 | 9.57 | 13.14 |
| Incyte Corporation (INCY)vs › | $25.96B | 7.85 | 3.38 | 2.74 | 2.31 |
| Quest Diagnostics Incorporated (DGX)vs › | $26.04B | 9.42 | 8.33 | 8.09 | 9.83 |
| Waters Corporation (WAT)vs › | $25.02B | 7.87 | 10.78 | 11.05 | 10.65 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.72B | 7.82 | 6.79 | 7.36 | 7.17 |
| Mettler-Toledo International Inc. (MTD)vs › | $28.06B | 42.71 | 41.42 | 39.43 | 36.04 |
| BioNTech SE (BNTX)vs › | $23.38B | -5.94 | -4.08 | 9.21 | 14.48 |
| DexCom, Inc. (DXCM)vs › | $28.88B | 2.34 | 1.80 | 1.48 | 1.30 |
| STERIS plc (STE)vs › | $22.45B | 7.93 | 7.08 | 4.77 | 4.37 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.16B | 3.27 | 4.46 | 4.05 | 4.25 |
Trailing EPS (TTM)
$11.29
Forward EPS (Est.)
$18.02
P/E Ratio
26.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 10.54 |
| 2024-12-31 | 8.89 |
| 2023-12-31 | 4.80 |
| 2022-12-31 | 14.04 |
| 2021-12-31 | 24.58 |
| 2020-12-31 | 15.99 |
| 2019-12-31 | 8.41 |
| 2018-12-31 | 8.71 |
| 2017-12-31 | 12.39 |
| 2016-12-31 | 7.14 |
| 2015-12-31 | 4.42 |
| 2014-12-31 | 6.03 |
| 2013-12-31 | 6.70 |
| 2012-12-31 | 6.24 |
| 2011-12-31 | 5.31 |
| 2010-12-31 | 5.45 |
| 2009-12-31 | 4.98 |
| 2008-12-31 | 4.60 |
| 2007-12-31 | 4.08 |
| 2006-12-31 | 3.48 |
| 2005-12-31 | 2.89 |
| 2004-12-31 | 2.60 |
| 2003-12-31 | 2.23 |
| 2002-12-31 | 1.78 |
| 2001-12-31 | 1.29 |
| 2000-12-31 | 0.83 |
| 1999-12-31 | 0.30 |
| 1998-12-31 | 0.50 |
| 1997-12-31 | -2.17 |
| 1996-12-31 | -3.12 |
